Naphthalimides exhibit in vitro antiproliferative and antiangiogenic activities by inhibiting both topoisomerase II (topo II) and receptor tyrosine kinases (RTKs).
Saved in:
| Title: | Naphthalimides exhibit in vitro antiproliferative and antiangiogenic activities by inhibiting both topoisomerase II (topo II) and receptor tyrosine kinases (RTKs). |
|---|---|
| Authors: | Wang, Xin1, Chen, Zhuo1,2 chenzhuo@ecust.edu.cn, Tong, Linjiang2, Tan, Shaoying1, Zhou, Wei1, Peng, Ting2, Han, Kun2, Ding, Jian2, Xie, Hua2 hxie@simm.ac.cn, Xu, Yufang1 yfxu@ecust.edu.cn |
| Source: | European Journal of Medicinal Chemistry. Jul2013, Vol. 65, p477-486. 10p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
